Psychedelics research company Champignon Brands SHRM SHRMF announced Friday it is acquiring AltMed Capital Corp.
Run by Dr. Roger McIntyre, AltMed has been operating a ketamine clinic, the Health Canada-approved Canadian Rapid Treatment Centre of Excellence (CRTCE), for more than 18 months now.
Dr. McIntyre is well known in his field, having published more than 600 articles. AltMed’s director, Pat McCutcheon, is the co-founder and CEO of MediPharm Labs LABS MEDIF.
Chatting with Benzinga, Dr. McIntyre said, "Our new corporation is the largest and most influential company in the world that integrates both research and development of ketamine and psychedelic medicines along with excellence in the multidisciplinary care of persons with mood and related disorders (e.g. PTSD, pain substance abuse)."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.